國立虎尾科技大學 |

Essentials of Hypertension = The 120/80 paradigm /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Essentials of Hypertension/ by Flávio Danni Fuchs.
其他題名:	The 120/80 paradigm /
作者:	Fuchs, Flávio Danni.
面頁冊數:	XIII, 151 p. 70 illus., 34 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Cardiology. -
電子資源:	https://doi.org/10.1007/978-3-319-63272-8
ISBN:	9783319632728

Essentials of Hypertension = The 120/80 paradigm /
Fuchs, Flávio Danni.

Essentials of HypertensionThe 120/80 paradigm /[electronic resource] :by Flávio Danni Fuchs. - 1st ed. 2018. - XIII, 151 p. 70 illus., 34 illus. in color.online resource.

Risks of high BP and goals of treatment -- Pathogenesis -- Diagnosis and evaluation -- Prevention and treatment.

The main purpose of this book is to select and present the most essential information about hypertension. It aims to select all the more relevant data to guide the attitudes to prevent, diagnose, and treat hypertension. Hypertension accounts for more than 50% of deaths from stroke and ischemic heart disease worldwide. New blood pressure (BP) diagnostic thresholds for hypertension were released, which were set at 130/80 mmHg. As a consequence, millions of individuals in the world will be diagnosed as hypertensive, recognizing that they are at greater risk of presenting a CV event. Prevention and control of high BP will become the main focus for reducing the burden of CV disease, requiring a changing of cultural beliefs in some way similar to what happened in the last century with smoking. Strategies for prevention of the rising of BP with age, and the BP reduction in individuals already with high levels, are more complex than those related to smoking control. These strategies involve solid evidence to be implemented in populations. The extensive scientific literature dealing with hypertension and BP regulation is among the top dedicated to a single disease. The chapters and contents follow the clinical reasoning pathways. The characterization of the risks of high blood pressure is presented in the first chapter, discussing the evidence that led to changes in diagnostic thresholds and to the recommendations for maintaining BP within these limits in populations. Reasons for BP rising with age will follow, identifying the causes that must be fought to preventing the incidence of hypertension. Diagnosis of hypertension deserves a special chapter. The final chapter presents the fundamentals to select drug and non-drug therapies indicated in the prevention and controlling of high blood pressure.

ISBN: 9783319632728

Standard No.: 10.1007/978-3-319-63272-8doiSubjects--Topical Terms:

593957
Cardiology.

LC Class. No.: RC681-688.2

Dewey Class. No.: 616.12

Essentials of Hypertension = The 120/80 paradigm /
LDR:03260nam a22003975i 4500 001 992328
003 DE-He213
005 20200630084145.0
007 cr nn 008mamaa
008 201225s2018 gw | s |||| 0|eng d
020 $a 9783319632728 $9 978-3-319-63272-8
024 7 $a 10.1007/978-3-319-63272-8 $2 doi
035 $a 978-3-319-63272-8
050 4 $a RC681-688.2
072 7 $a MJD $2 bicssc
072 7 $a MED010000 $2 bisacsh
072 7 $a MJD $2 thema
082 0 4 $a 616.12 $2 23
100 1 $a Fuchs, Flávio Danni. $e author. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1284042
245 1 0 $a Essentials of Hypertension $h [electronic resource] : $b The 120/80 paradigm / $c by Flávio Danni Fuchs.
250 $a 1st ed. 2018.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2018.
300 $a XIII, 151 p. 70 illus., 34 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Risks of high BP and goals of treatment -- Pathogenesis -- Diagnosis and evaluation -- Prevention and treatment.
520 $a The main purpose of this book is to select and present the most essential information about hypertension. It aims to select all the more relevant data to guide the attitudes to prevent, diagnose, and treat hypertension. Hypertension accounts for more than 50% of deaths from stroke and ischemic heart disease worldwide. New blood pressure (BP) diagnostic thresholds for hypertension were released, which were set at 130/80 mmHg. As a consequence, millions of individuals in the world will be diagnosed as hypertensive, recognizing that they are at greater risk of presenting a CV event. Prevention and control of high BP will become the main focus for reducing the burden of CV disease, requiring a changing of cultural beliefs in some way similar to what happened in the last century with smoking. Strategies for prevention of the rising of BP with age, and the BP reduction in individuals already with high levels, are more complex than those related to smoking control. These strategies involve solid evidence to be implemented in populations. The extensive scientific literature dealing with hypertension and BP regulation is among the top dedicated to a single disease. The chapters and contents follow the clinical reasoning pathways. The characterization of the risks of high blood pressure is presented in the first chapter, discussing the evidence that led to changes in diagnostic thresholds and to the recommendations for maintaining BP within these limits in populations. Reasons for BP rising with age will follow, identifying the causes that must be fought to preventing the incidence of hypertension. Diagnosis of hypertension deserves a special chapter. The final chapter presents the fundamentals to select drug and non-drug therapies indicated in the prevention and controlling of high blood pressure.
650 0 $a Cardiology. $3 593957
650 0 $a Nephrology. $3 668354
650 0 $a Neurology . $3 1253459
650 0 $a Primary care (Medicine). $3 1254357
650 2 4 $a Neurology. $3 593894
650 2 4 $a Primary Care Medicine. $3 673694
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319632711
776 0 8 $i Printed edition: $z 9783319632735
776 0 8 $i Printed edition: $z 9783319875149
856 4 0 $u https://doi.org/10.1007/978-3-319-63272-8
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)